Aug. 2016: LKQ Corp. (Stock to Study), Gilead Sciences (Undervalued)The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced LKQ Corporation (NDQ: LKQ) as its August 2016 "Stock to Study" and Gilead Sciences, Inc. (NDQ: GILD) as its August 2016 "Undervalued Stock" for investors' informational and educational use.
"The committee selected LKQ for its consistent historical growth, continued opportunities for growth in providing replacement auto parts and reasonable current valuation," said Adam Ritt, editor of BetterInvesting Magazine. "For the Undervalued selection, the committee believes that Gilead Sciences could benefit from recent developments in HIV and hepatitis C treatments and that the current valuation is extremely reasonable."
Check BetterInvesting's August issue for more details about these selections. Go to the trial version of BetterInvesting's online tools to study the investment potential of LKQ and Gilead Sciences by viewing their fundamental data and applying judgments.
Committee members are Kenneth M. Bernard, CFA; Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip S. Dano, CFA; Donald E. Danko, CFA; Maury Elvekrog, CFA; and Walter J. Kirchberger, CFA.
As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.